White House Asks Walgreens, CVS, Walmart for Help Promoting Drug-Cost Law
- Inflation Reduction Act is seen as key to Biden’s reelection
- Help sought in promoting cost-saving programs for elderly
A pharmacy technician fills a prescription in Portland, Maine.
Photographer: Joe Raedle/Getty ImagesThis article is for subscribers only.
Biden administration officials asked executives from major drug and retail chains to counter stiff opposition from the pharmaceutical industry and help promote a law intended to lower drug costs.
US health officials met Tuesday at the White House with leaders of CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc., seeking help to tout the benefits of the Inflation Reduction Act, a Health and Human Services Department spokesperson said. Along with capping insulin prices and expanding access to adult vaccines, the law will allow Medicare, the US health program for the elderly, to negotiate prices of costly drugs made by some of the biggest pharmaceutical companies.